Strategic Intent:

Navilyst Medical strives to be the first choice provider of medical devices for vascular access, and the diagnosis and treatment of vascular disease.

Market: 
With a focus on the vascular (circulatory) system, Navilyst Medical’s technologies have an abundance of clinical applications. Its products are used in 76 countries by healthcare providers including interventional radiologists, interventional cardiologists, oncologists, surgeons, IV nurses, and oncology nurses. In addition, infection preventionists, vascular access technicians and hospital administrators rely on Navilyst Medical products and clinical training to address the upcoming change by The Centers for Medicare and Medicaid Services (CMS), which will no longer reimburse charges associated with catheter-related bloodstream infections (CR-BSIs) as of October 1, 2008.

Commitment to Clinical Training and Preventing Catheter-Related Bloodstream Infections (CR-BSIs)

Navilyst Medical recognizes that proper care and maintenance of central venous catheters and other devices are critical to infection control. The company works hand-in-hand with its customers to provide up-to-date education as part of a hospital’s overall infection prevention strategy.